Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,764 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of dystonia in Europe: a survey of the European network for the study of the dystonia syndromes.
Valadas A, Contarino MF, Albanese A, Bhatia KP, Falup-Pecurariu C, Forsgren L, Friedman A, Giladi N, Hutchinson M, Kostic VS, Krauss JK, Lokkegaard A, Marti MJ, Milanov I, Pirtosek Z, Relja M, Skorvanek M, Stamelou M, Stepens A, Tamás G, Taravari A, Tzoulis C, Vandenberghe W, Vidailhet M, Ferreira JJ, Tijssen MA. Valadas A, et al. Among authors: friedman a. Eur J Neurol. 2016 Apr;23(4):772-9. doi: 10.1111/ene.12940. Epub 2016 Jan 29. Eur J Neurol. 2016. PMID: 26826067
Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.
Ferreira JJ, Katzenschlager R, Bloem BR, Bonuccelli U, Burn D, Deuschl G, Dietrichs E, Fabbrini G, Friedman A, Kanovsky P, Kostic V, Nieuwboer A, Odin P, Poewe W, Rascol O, Sampaio C, Schüpbach M, Tolosa E, Trenkwalder C, Schapira A, Berardelli A, Oertel WH. Ferreira JJ, et al. Among authors: friedman a. Eur J Neurol. 2013 Jan;20(1):5-15. doi: 10.1111/j.1468-1331.2012.03866.x. Eur J Neurol. 2013. PMID: 23279439 Review.
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease.
Horstink M, Tolosa E, Bonuccelli U, Deuschl G, Friedman A, Kanovsky P, Larsen JP, Lees A, Oertel W, Poewe W, Rascol O, Sampaio C; European Federation of Neurological Societies; Movement Disorder Society-European Section. Horstink M, et al. Among authors: friedman a. Eur J Neurol. 2006 Nov;13(11):1170-85. doi: 10.1111/j.1468-1331.2006.01547.x. Eur J Neurol. 2006. PMID: 17038031 Review.
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease.
Horstink M, Tolosa E, Bonuccelli U, Deuschl G, Friedman A, Kanovsky P, Larsen JP, Lees A, Oertel W, Poewe W, Rascol O, Sampaio C; European Federation of Neurological Societies; Movement Disorder Society-European Section. Horstink M, et al. Among authors: friedman a. Eur J Neurol. 2006 Nov;13(11):1186-202. doi: 10.1111/j.1468-1331.2006.01548.x. Eur J Neurol. 2006. PMID: 17038032 Review.
Risk of Seizure Recurrence Due to Autoimmune Encephalitis With NMDAR, LGI1, CASPR2, and GABABR Antibodies: Implications for Return to Driving.
Rada A, Hagemann A, Aaberg Poulsen C, Baumgartner T, Berki T, Blaabjerg M, Brenner J, Britton JW, Christiana A, Ciano-Petersen NL, Crijnen Y, Elišák M, Farina A, Friedman AR, Hayden Z, Hébert J, Holtkamp M, Hong Z, Honnorat J, Ilyas-Feldmann M, Irani SR, Kovac S, Marusic P, Muñiz-Castrillo S, Ramanathan S, Smith KM, Steriade C, Strippel C, Surges R, Titulaer MJ, Uy CE, de Vries JM, Bien CG, Specht U. Rada A, et al. Among authors: friedman ar. Neurol Neuroimmunol Neuroinflamm. 2024 Jul;11(4):e200225. doi: 10.1212/NXI.0000000000200225. Epub 2024 Jun 4. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38838283 Free article.
Anifrolumab for the Dermatologist.
Whiting C, Azim SA, Friedman A. Whiting C, et al. Among authors: friedman a. J Drugs Dermatol. 2024 Jun 1;23(6):489-490. doi: 10.36849/JDD.0624. J Drugs Dermatol. 2024. PMID: 38834227 No abstract available.
3,764 results